{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:14:34Z","timestamp":1791566074083,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.clim.2022.109074","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T19:50:29Z","timestamp":1657137029000},"page":"109074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Kelch-like protein 11 antibody-associated paraneoplastic neurological syndrome: A state-of-the-art review"],"prefix":"10.1016","volume":"241","author":[{"given":"Er-Chuang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Lun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ting","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao-Li","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Qing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2022.109074_bb0005","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system","volume":"349","author":"Darnell","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2022.109074_bb0010","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.clim.2022.109074_bb0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMoa1816721","article-title":"Kelch-like protein 11 antibodies in seminoma-associated paraneoplastic encephalitis","volume":"381","author":"Mandel-Brehm","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2022.109074_bb0020","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jamaneurol.2021.1557","article-title":"Ondine\u2019s curse and trismus in association with Kelch-like Protein-11 autoimmunity","volume":"78","author":"Devine","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clim.2022.109074_bb0025","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jamaneurol.2020.2231","article-title":"Expanded clinical phenotype, oncological associations, and Immunopathologic insights of paraneoplastic Kelch-like Protein-11 encephalitis","volume":"77","author":"Dubey","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clim.2022.109074_bb0030","doi-asserted-by":"crossref","first-page":"fcab185","DOI":"10.1093\/braincomms\/fcab185","article-title":"Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis","volume":"3","author":"Vogrig","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.clim.2022.109074_bb0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13760-021-01813-z","article-title":"Comment on \u201cparaneoplastic encephalomyelitis revealing burned-out seminoma\u201d: confirmed case of anti-Kelch-like protein-11 encephalomyelitis","volume":"122","author":"Maldonado Slootjes","year":"2021","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.clim.2022.109074_bb0040","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s13760-020-01447-7","article-title":"Paraneoplastic encephalomyelitis revealing burned-out seminoma","volume":"121","author":"Guilmot","year":"2021","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.clim.2022.109074_bb0045","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000666","article-title":"Clinical significance of Kelch-like protein 11 antibodies","volume":"7","author":"Maudes","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.clim.2022.109074_bb0050","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1111\/ene.15120","article-title":"Long-term MRI changes in a patient with Kelch-like protein 11-associated paraneoplastic neurological syndrome","volume":"28","author":"Ishikawa","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clim.2022.109074_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577570","article-title":"Opsoclonus-myoclonus syndrome associated with anti Kelch-like protein-11 antibodies in a young female patient without cancer","volume":"355","author":"Fonseca","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2022.109074_bb0060","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1002\/mdc3.13284","article-title":"Paraneoplastic syndrome associated with Kelch-like protein 11 antibodies presenting with progressive Ataxia and tremor","volume":"8","author":"Prakash","year":"2021","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.clim.2022.109074_bb0065","doi-asserted-by":"crossref","first-page":"e2668","DOI":"10.1212\/WNL.0000000000011711","article-title":"Teaching video NeuroImages: periodic alternating nystagmus in paraneoplastic KLHL11 Rhomboencephalitis","volume":"96","author":"Bohm","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2022.109074_bb0070","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1212\/WNL.0000000000009895","article-title":"Clinical and imaging features of newly recognized Kelch-like protein 11 paraneoplastic syndrome","volume":"95","author":"Wong","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2022.109074_bb0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/WNO.0000000000001194","article-title":"Paraneoplastic progressive downbeat nystagmus, Ataxia and sensorineural hearing loss due to the ANTI-Kelch-11 protein antibody","volume":"41","author":"Kattah","year":"2021","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.clim.2022.109074_bb0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00415-019-09544-1","article-title":"Epidemiology of paraneoplastic neurological syndromes: a population-based study","volume":"267","author":"Vogrig","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.clim.2022.109074_bb0085","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2022.109074_bb0090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1479-7364-7-13","article-title":"Update on the Kelch-like (KLHL) gene family","volume":"7","author":"Dhanoa","year":"2013","journal-title":"Hum. Genom."},{"key":"10.1016\/j.clim.2022.109074_bb0095","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/jnnp-2021-326775","article-title":"Paraneoplastic cochleovestibulopathy: clinical presentations, oncological and serological associations","volume":"92","author":"Hammami","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clim.2022.109074_bb0100","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jnnp-2020-325569","article-title":"Association between paraneoplastic rhombencephalitis and hypertrophic olivary degeneration","volume":"92","author":"Madhavan","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clim.2022.109074_bb0105","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420985323","article-title":"Paraneoplastic neurological syndromes: clinical presentations and management","volume":"14","author":"Devine","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.clim.2022.109074_bb0110","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11912-018-0721-y","article-title":"Updates in the diagnosis and treatment of paraneoplastic neurologic syndromes","volume":"20","author":"Grativvol","year":"2018","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.clim.2022.109074_bb0115","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/jnnp-2017-316904","article-title":"Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies","volume":"89","author":"Berzero","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clim.2022.109074_bb0120","first-page":"362","article-title":"Paraneoplastic neurological syndrome: an evolving story","volume":"8","author":"Jitprapaikulsan","year":"2021","journal-title":"Neurooncol. Pract."},{"key":"10.1016\/j.clim.2022.109074_bb0125","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41571-019-0194-4","article-title":"Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors","volume":"16","author":"Graus","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.clim.2022.109074_bb0130","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/ana.26050","article-title":"Leucine zipper 4 autoantibody: a novel germ cell tumor and paraneoplastic biomarker","volume":"89","author":"Dubey","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2022.109074_bb0135","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ejpn.2015.06.005","article-title":"Anti-Ma2-encephalitis in a 2 year-old child: a newly diagnosed case and literature review","volume":"19","author":"Mrabet","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.clim.2022.109074_bb0140","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2-associated encephalitis","volume":"127","author":"Dalmau","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.clim.2022.109074_bb0145","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jalm\/jfab127","article-title":"Clinical sensitivity, specificity, and predictive value of neural antibody testing for autoimmune encephalitis","volume":"7","author":"Budhram","year":"2022","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.clim.2022.109074_bb0150","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/acn3.328","article-title":"Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review","volume":"3","author":"Venkatraman","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.clim.2022.109074_bb0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40164-016-0058-x","article-title":"Paraneoplastic neurological complications of breast cancer","volume":"5","author":"Fanous","year":"2015","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.clim.2022.109074_bb0160","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.10518","article-title":"Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments","volume":"53","author":"Pittock","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2022.109074_bb0165","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12883-016-0657-5","article-title":"Intrathecal synthesis of anti-Hu antibodies distinguishes patients with paraneoplastic peripheral neuropathy and encephalitis","volume":"16","author":"Schwenkenbecher","year":"2016","journal-title":"BMC Neurol."},{"key":"10.1016\/j.clim.2022.109074_bb0170","doi-asserted-by":"crossref","first-page":"38216","DOI":"10.1038\/srep38216","article-title":"Anti-Hu antibodies activate enteric and sensory neurons","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2022.109074_bb0175","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/WCO.0000000000000677","article-title":"Neurological profiles beyond the sleep disorder in patients with anti-IgLON5 disease","volume":"32","author":"Gaig","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.clim.2022.109074_bb0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11940-018-0515-4","article-title":"Anti-IgLON 5 disease","volume":"20","author":"Heidbreder","year":"2018","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.clim.2022.109074_bb0185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41582-020-0359-x","article-title":"GAD antibodies in neurological disorders - insights and challenges","volume":"16","author":"Graus","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.clim.2022.109074_bb0190","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211003486","article-title":"GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions","volume":"14","author":"Tsiortou","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.clim.2022.109074_bb0195","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","article-title":"Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies","volume":"72","author":"Ari\u00f1o","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clim.2022.109074_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121364","article-title":"Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity","volume":"10","author":"Gresa-Arribas","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2022.109074_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103701","article-title":"Neurological syndromes associated with anti-GAD antibodies","volume":"21","author":"Dade","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2022.109074_bb0210","doi-asserted-by":"crossref","first-page":"e3012","DOI":"10.1212\/WNL.0000000000010854","article-title":"Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis","volume":"95","author":"Spatola","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2022.109074_bb0215","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/01.WNL.0000041495.87539.98","article-title":"Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease","volume":"60","author":"Bernal","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2022.109074_bb0220","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ana.24872","article-title":"Microtubule-associated protein 1B: novel paraneoplastic biomarker","volume":"81","author":"Gadoth","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2022.109074_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.729075","article-title":"CRMP5 antibodies-diagnostic challenges","volume":"12","author":"Totland","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clim.2022.109074_bb0230","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/jnnp-2021-326656","article-title":"Characterisation of TRIM46 autoantibody-associated paraneoplastic neurological syndrome","volume":"93","author":"Valencia-Sanchez","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622001553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622001553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:07:31Z","timestamp":1761494851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661622001553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":46,"alternative-id":["S1521661622001553"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2022.109074","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kelch-like protein 11 antibody-associated paraneoplastic neurological syndrome: A state-of-the-art review","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2022.109074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109074"}}